Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Shubhi Srivastava, Vinaya Vishwanathan, Abhijit Birje, Devanjan Sinha & Patrick D’Silva. (2019) Evolving paradigms on the interplay of mitochondrial Hsp70 chaperone system in cell survival and senescence. Critical Reviews in Biochemistry and Molecular Biology 54:6, pages 517-536.
Read now
Read now
Pui-Kei Wu, Seung-Keun Hong & Jong-In Park. (2017) Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in KRAS and BRAF Tumor Cells. Molecular and Cellular Biology 37:18.
Read now
Read now
Seung-Keun Hong, Dmytro Starenki, Pui-Kei Wu & Jong-In Park. (2017) Suppression of B-RafV600E melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinone. Cancer Biology & Therapy 18:2, pages 106-114.
Read now
Read now
Yinghua Li, Zhengfang Lin, Mingqi Zhao, Tiantian Xu, Changbing Wang, Huimin Xia, Hanzhong Wang & Bing Zhu. (2016) Multifunctional selenium nanoparticles as carriers of HSP70 siRNA to induce apoptosis of HepG2 cells. International Journal of Nanomedicine 11, pages 3065-3076.
Read now
Read now
Articles from other publishers (50)
Ji-Eun Bae, Soyoung Jang, Joon Bum Kim, Hyejin Hyung, Na Yeon Park, Yong Hwan Kim, So Hyun Kim, Seong Hyun Kim, Jin Min Ha, Gyeong Seok Oh, Kyuhee Park, Kwiwan Jeong, Jae Seon Jang, Doo Sin Jo, Pansoo Kim, Hyun-Shik Lee, Zae Young Ryoo & Dong-Hyung Cho. (2023) Enhanced primary ciliogenesis via mitochondrial oxidative stress activates AKT to prevent neurotoxicity in HSPA9/mortalin-depleted SH-SY5Y cells. Molecular Brain 16:1.
Crossref
Crossref
Niki Esfahanian, Cole D. Knoblich, Gaven A. Bowman & Khosrow Rezvani. (2023) Mortalin: Protein partners, biological impacts, pathological roles, and therapeutic opportunities. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Joseph R. Inigo & Dhyan Chandra. (2022) The mitochondrial unfolded protein response (UPRmt): shielding against toxicity to mitochondria in cancer. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Rajani Rai, Vishal Chandra, Amy L. Kennedy, Rosemary E. Zuna & Doris Mangiaracina Benbrook. (2022) Distinct mechanism of cervical cancer cell death caused by the investigational new drug SHetA2. Frontiers in Oncology 12.
Crossref
Crossref
Hazna Noor Meidinna, Seyad Shefrin, Anissa Nofita Sari, Huayue Zhang, Jaspreet Kaur Dhanjal, Sunil C. Kaul, Durai Sundar & Renu Wadhwa. (2022) Identification of a new member of Mortaparib class of inhibitors that target mortalin and PARP1. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Karl M. Laurin, Katherine Coutu-Beaudry, Alejandro Salazar, Nour Méribout, Étienne Audet-Walsh & Simon-Pierre Gravel. (2022) Low expression of PGC-1β and other mitochondrial biogenesis modulators in melanoma is associated with growth arrest and the induction of an immunosuppressive gene expression program dependent on MEK and IRF-1. Cancer Letters 541, pages 215738.
Crossref
Crossref
A-Rum Yoon, Renu Wadhwa, Sunil C Kaul & Chae-Ok Yun. (2022) Why is Mortalin a Potential Therapeutic Target for Cancer?. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Ahmed Elwakeel. (2022) Abrogating the Interaction Between p53 and Mortalin (Grp75/HSPA9/mtHsp70) for Cancer Therapy: The Story so far. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Ge Wang, Yumei Fan, Pengxiu Cao & Ke Tan. (2022) Insight into the mitochondrial unfolded protein response and cancer: opportunities and challenges. Cell & Bioscience 12:1.
Crossref
Crossref
Andrew E. Becker, Pui-Kei Wu & Jong-In Park. (2021) eIF5A-Independent Role of DHPS in p21CIP1 and Cell Fate Regulation. International Journal of Molecular Sciences 22:24, pages 13187.
Crossref
Crossref
Ying Xing, Yang Liu, Zhong Qi, Zhengrong Liu, Xin Wang & Hongyi Zhang. (2021) LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway. Cellular & Molecular Biology Letters 26:1.
Crossref
Crossref
Michael S. Petronek, Douglas R. Spitz & Bryan G. Allen. (2021) Iron–Sulfur Cluster Biogenesis as a Critical Target in Cancer. Antioxidants 10:9, pages 1458.
Crossref
Crossref
Ye Yang, Ming Jin, Yi Dai, Wenqi Shan, Shuai Chen, Rong Cai, Haojun Yang, Liming Tang & Lei Li. (2021) Involvement and Targeted Intervention of Mortalin-Regulated Proteome Phosphorylated-Modification in Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Yi Qian, Meimei Zhao, Qinghua Han, Jingkang Wang, Lixi Liao, Heng Yang, Dan Liu, Pengfei Tu, Hong Liang & Kewu Zeng. (2021) Pharmacologically targeting molecular motor promotes mitochondrial fission for anti-cancer. Acta Pharmaceutica Sinica B 11:7, pages 1853-1866.
Crossref
Crossref
Yuning Liao, Yuan Liu, Zhenlong Shao, Xiaohong Xia, Yuanfei Deng, Jianyu Cai, Leyi Yao, Jinchan He, Cuifu Yu, Tumei Hu, Wenshuang Sun, Fang Liu, Daolin Tang, Jinbao Liu & Hongbiao Huang. (2021) A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance. Oncogene 40:25, pages 4291-4306.
Crossref
Crossref
Pui-Kei Wu, Seung-Keun Hong & Jong-In Park. (2021) Mortalin depletion induces MEK/ERK-dependent and ANT/CypD-mediated death in vemurafenib-resistant B-RafV600E melanoma cells. Cancer Letters 502, pages 25-33.
Crossref
Crossref
Anissa Nofita Sari, Ahmed Elwakeel, Jaspreet Kaur Dhanjal, Vipul Kumar, Durai Sundar, Sunil C. Kaul & Renu Wadhwa. (2021) Identification and Characterization of MortaparibPlus—A Novel Triazole Derivative That Targets Mortalin-p53 Interaction and Inhibits Cancer-Cell Proliferation by Wild-Type p53-Dependent and -Independent Mechanisms. Cancers 13:4, pages 835.
Crossref
Crossref
Hao Wu, Xian-Yu Zhang, Ming Niu, Fei-Feng Li, Song Gao, Wei Wei, Si-Wei Li, Xing-Da Zhang, Shu-Lin Liu & Da Pang. (2020) Isobaric Tags for Relative and Absolute Quantitation in Proteomic Analysis of Potential Biomarkers in Invasive Cancer, Ductal Carcinoma In Situ, and Mammary Fibroadenoma. Frontiers in Oncology 10.
Crossref
Crossref
Pui-Kei Wu, Andrew Becker & Jong-In Park. (2020) Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway. International Journal of Molecular Sciences 21:15, pages 5436.
Crossref
Crossref
Pui-Kei Wu, Seung-Keun Hong, Dmytro Starenki, Kiyoko Oshima, Hao Shao, Jason E. Gestwicki, Susan Tsai & Jong-In Park. (2020) Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability. Oncogene 39:21, pages 4257-4270.
Crossref
Crossref
Pui-Kei Wu, Seung-Keun HongWenjing ChenAndrew E. BeckerRebekah L. Gundry, Chien-Wei LinHao Shao, Jason E. GestwickiJong-In Park. (2020)
Mortalin (HSPA9) facilitates
BRAF
-mutant tumor cell survival by suppressing ANT3-mediated mitochondrial membrane permeability
. Science Signaling 13:622.
Crossref
Crossref
B. B. Guda, V. V. Pushkarev, O. I. Kovzun, V. P. Pushkarev & M. D. Tronko. (2019) Токсичність МАРК у карциномах щитоподібної залози. Механізми пригнічення сигнального каскаду (огляд літератури та власних даних). Шпитальна хірургія. Журнал імені Л. Я. Ковальчука:3, pages 84-96.
Crossref
Crossref
Vinayak Narayanankutty, Arunaksharan Narayanankutty & Anusree Nair. (2019) Heat Shock Proteins (HSPs): A Novel Target for Cancer Metastasis Prevention. Current Drug Targets 20:7, pages 727-737.
Crossref
Crossref
Dmytro Starenki, Nadiya Sosonkina, Seung-Keun Hong, Ricardo V. Lloyd & Jong-In Park. (2019) Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells. International Journal of Molecular Sciences 20:9, pages 2069.
Crossref
Crossref
William Antholine, Jeannette Vasquez-Vivar, Brendan Quirk, Harry Whelan, Pui Wu, Jong-In Park & Charles Myers. (2019) Treatment of Cells and Tissues with Chromate Maximizes Mitochondrial 2Fe2S EPR Signals. International Journal of Molecular Sciences 20:5, pages 1143.
Crossref
Crossref
Gwo-Jen Liaw & Chuen-Sheue Chiang. (2019) Inactive Tlk associating with Tak1 increases p38 MAPK activity to prolong the G2 phase. Scientific Reports 9:1.
Crossref
Crossref
Sanam Sane, Andre Hafner, Rekha Srinivasan, Daniall Masood, John l. Slunecka, Collin J. Noldner, Alex D. Hanson, Taylor Kruisselbrink, Xuejun Wang, Yiyang Wang, Jun Yin & Khosrow Rezvani. (2018) UBXN2A enhances CHIP‐mediated proteasomal degradation of oncoprotein mortalin‐2 in cancer cells. Molecular Oncology 12:10, pages 1753-1777.
Crossref
Crossref
Laura C. Hernández-Ramírez, Rhodri M.L. Morgan, Sayka Barry, Fulvio D’Acquisto, Chrisostomos Prodromou & Márta Korbonits. (2018) Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland. Oncotarget 9:10, pages 9177-9198.
Crossref
Crossref
V. M. Pushkarev, B. B. Guda, V. V. Pushkarev & N. D. Tronko. (2018) Oncogene toxicity in thyroid carcinomas and other types of tumors. Cytology and Genetics 52:1, pages 54-61.
Crossref
Crossref
Seung-Keun Hong, Pui-Kei Wu & Jong-In Park. (2018) A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses. Cellular Signalling 42, pages 11-20.
Crossref
Crossref
Zhihui Gao, Xiuran Niu, Qing Zhang, Hang Chen, Aiai Gao, Shanshan Qi, Rong Xiang, Mattias Belting & Sihe Zhang. (2017) Mitochondria chaperone GRP75 moonlighting as a cell cycle controller to derail endocytosis provides an opportunity for nanomicrosphere intracellular delivery. Oncotarget 8:35, pages 58536-58552.
Crossref
Crossref
Xuelian Cui, Zhenling Li, Junjie Piao, Jinzi Li, Longshan Li, Zhenhua Lin & Aihua Jin. (2017) Mortalin expression in pancreatic cancer and its clinical and prognostic significance. Human Pathology 64, pages 171-178.
Crossref
Crossref
Martijn Kerkhofs, Carlotta Giorgi, Saverio Marchi, Bruno Seitaj, Jan B. Parys, Paolo Pinton, Geert Bultynck & Mart Bittremieux. 2017. Organelle Contact Sites. Organelle Contact Sites
225
254
.
B. B. Guda, V. V. Pushkarev, O. V. Zhuravel, A. Ye. Kovalenko, V. M. Pushkarev, Y. M. Taraschenko & M. D. Tronko. (2016) Protein kinase Akt activity in human thyroid tumors. The Ukrainian Biochemical Journal 88:5, pages 90-95.
Crossref
Crossref
Khosrow Rezvani. (2016) UBXD Proteins: A Family of Proteins with Diverse Functions in Cancer. International Journal of Molecular Sciences 17:10, pages 1724.
Crossref
Crossref
Sanam Sane, Ammara Abdullah, Morgan E. Nelson, Hongmin Wang, Subhash C. Chauhan, Samuel S. Newton & Khosrow Rezvani. (2015) Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy. Cell Stress and Chaperones 21:2, pages 313-326.
Crossref
Crossref
B.B. Guda, V.M. Pushkarev, O.V. Zhuravel, A.Ye. Kovalenko, V.V. Pushkarev, Y.M. Tarashchenko, L.Y. Zurnadzhy, O.I. Kovzun & M.D. Tronko. (2016) Expression and activity of extracellular signal-regulated kinase-1/2 (ERK1/2) in normal tissues and human thyroid tumors. Reports of the National Academy of Sciences of Ukraine:1, pages 105-109.
Crossref
Crossref
Seung-Keun Hong, Pui-Kei Wu, Mansi Karkhanis & Jong-In Park. (2015) ERK1/2 can feedback-regulate cellular MEK1/2 levels. Cellular Signalling 27:10, pages 1939-1948.
Crossref
Crossref
Ammara Abdullah, Sanam Sane, Kate A. Branick, Jessica L. Freeling, Hongmin Wang, Dong Zhang & Khosrow Rezvani. (2015) A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2. Oncotarget 6:27, pages 23561-23581.
Crossref
Crossref
D Starenki, S-K Hong, R V Lloyd & J-I Park. (2014) Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells. Oncogene 34:35, pages 4624-4634.
Crossref
Crossref
Pui–Kei Wu, Seung–Keun Hong, Seung–Hee Yoon & Jong–In Park. (2015)
Active
ERK
2 is sufficient to mediate growth arrest and differentiation signaling
. The FEBS Journal 282:6, pages 1017-1030.
Crossref
Crossref
Mansi Karkhanis & Jong-In Park. (2015) Sp1 regulates Raf/MEK/ERK-induced p21CIP1 transcription in TP53-mutated cancer cells. Cellular Signalling 27:3, pages 479-486.
Crossref
Crossref
Dmytro StarenkiJong-In Park. (2015)
Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival
In Vitro
and
In Vivo
. Endocrinology and Metabolism 30:4, pages 593.
Crossref
Crossref
Nadiya Sosonkina, Seung-Keun Hong, Dmytro Starenki & Jong-In Park. (2014) Kinome sequencing reveals RET G691S polymorphism in human neuroendocrine lung cancer cell lines. Genes & Genomics 36:6, pages 829-841.
Crossref
Crossref
Noor O. Baqader, Marko Radulovic, Mark Crawford, Kai Stoeber & Jasminka Godovac-Zimmermann. (2014) Nuclear Cytoplasmic Trafficking of Proteins is a Major Response of Human Fibroblasts to Oxidative Stress. Journal of Proteome Research 13:10, pages 4398-4423.
Crossref
Crossref
Jin-Hwan Kim, Seung-Keun Hong, Pui-Kei Wu, Alexsia L. Richards, William T. Jackson & Jong-In Park. (2014) Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levels. Experimental Cell Research 327:2, pages 340-352.
Crossref
Crossref
YAN ZHANG, MENG-LI GU, XIN-XIN ZHOU, HAN MA, HANG-PING YAO & FENG JI. (2014) Altered expression of ETV1 and its contribution to tumorigenic phenotypes in gastrointestinal stromal tumors. Oncology Reports 32:3, pages 927-934.
Crossref
Crossref
Jihoon Ryu, Zeenia Kaul, A-Rum Yoon, Ye Liu, Tomoko Yaguchi, Youjin Na, Hyo Min Ahn, Ran Gao, Il-Kyu Choi, Chae-Ok Yun, Sunil C. Kaul & Renu Wadhwa. (2014) Identification and Functional Characterization of Nuclear Mortalin in Human Carcinogenesis. Journal of Biological Chemistry 289:36, pages 24832-24844.
Crossref
Crossref
Jong-In Park. (2014) Growth arrest signaling of the Raf/MEK/ERK pathway in cancer. Frontiers in Biology 9:2, pages 95-103.
Crossref
Crossref
Morteza Hemmat, Weina Chen, Arturo Anguiano, Mohammed Naggar, Frederick K Racke, Dan Jones, Yongbao Wang, Charles M Strom, Karl Chang & Fatih Z Boyar. (2014) Submicroscopic deletion of 5q involving tumor suppressor genes (CTNNA1, HSPA9) and copy neutral loss of heterozygosity associated with TET2 and EZH2 mutations in a case of MDS with normal chromosome and FISH results. Molecular Cytogenetics 7:1, pages 35.
Crossref
Crossref